Market Tracker

01/20 5:16pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

1.01
Delayed Data
As of Jan 20
 0.00 / 0.00%
Today’s Change
0.49
Today|||52-Week Range
3.05
+3.08%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close1.01
Today’s open1.03
Day’s range0.99 - 1.03
Volume268,277
Average volume (3 months)638,154
Market cap$29.7M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-12.82%
Earnings growth (this year)+7.95%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.67

Competitors

 Today’s
change
Today’s
% change
INISInternational Isotop...0.000.00%
CGIXCancer Genetics Inc+0.05+2.70%
BMRABiomerica Inc+0.20+8.44%
TRILTrillium Therapeutic...-0.10-1.96%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 21, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$20.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Chief Medical Officer &
Director
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts